About the journal
The central focus of the journal is on research that advances understanding of existing and new neuropsychopharmacological agents including their mode of action and clinical application or provides insights into the biological basis of psychiatric disorders and thereby advances their pharmacological treatment. Such research may derive from the full spectrum of biological and psychological fields of inquiry encompassing classical and novel techniques in neuropsychopharmacology as well as strategies such as neuroimaging, genetics, psychoneuroendocrinology and neuropsychology.
Emphasis is given to original research (in the form of full-length papers and brief reports), which is of wide interest and clearly advances the field. Selected review articles and papers that highlight novel trends and perspectives are also considered.
Impact Factor and Ranking
| Year | Impact Factor | Si: Clinical Neurology | Si: Neurosciences | Si: Pharmacology & Pharmacy | Si: Psychiatry |
|---|---|---|---|---|---|
| 2023 | 4.5 | 42 out of 277 | 70 out of 310 | 60 out of 354 | 45 out of 276 |
| 2022 | 4.8 | 48 out of 212 | 80 out of 272 | 66 out of 277 | - |
| 2020 | 5.176 | 45 out of 208 | 77 out of 273 | 57 out of 275 | - |
| 2019 | 4.333 | 42 out of 204 | 76 out of 271 | 47 out of 271 | - |
| 2018 | 4.207 | 40 out of 199 | 73 out of 267 | 45 out of 267 | - |
| 2017 | 3.981 | 42 out of 197 | 71 out of 261 | 42 out of 261 | - |
| 2016 | 4.712 | 28 out of 194 | 51 out of 259 | 29 out of 257 | - |
| 2015 | 4.333 | 35 out of 193 | 62 out of 256 | 40 out of 255 | - |
| 2014 | 4.009 | 30 out of 192 | 65 out of 252 | 40 out of 255 | - |
| 2013 | 5.264 | 19 out of 194 | 42 out of 252 | 20 out of 256 | - |
| 2012 | 5.641 | 14 out of 193 | 32 out of 252 | 15 out of 261 | - |
| 2011 | 4.578 | 22 out of 192 | 50 out of 244 | 29 out of 261 | - |
| 2010 | 4.699 | 24 out of 185 | 46 out of 239 | 24 out of 252 | - |
This information is taken from the Journal Citation Reports™ from Clarivate, 2024, published annually as part of the Science Citation Index by the Web of Science Group.
IJNP by the Numbers
- Ranked in the top 25% of journals in Psychiatry, Clinical Neurology, and Pharmacology
- Wide distribution of readers in Asia (14%), Europe (27%), and North America (42%)
- 4.5 Impact Factor
- Average 9.1 days from receipt in production to online proof publication
- Average 31.4 days from submission to first decision
